ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Specialist

Top Specialist Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HECTOR FLORENTINO

Specialist

29,189

$2.71M

811
733 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 36%

$93
Average prescription price

Avg: $117

ROBERT RIZZO M.D.

Specialist

20,287

$1.21M

815
563 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 36%

$60
Average prescription price

Avg: $117

SUGANTHINI UMAKANTHAN MD

Specialist

19,352

$1.16M

727
679 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

2%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 36%

$60
Average prescription price

Avg: $117

ELI DJEBIYAN MD

Specialist

17,042

$1.12M

540
417 are 65+

19%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 36%

$66
Average prescription price

Avg: $117

FRANCISCO MUNOZ

Specialist

16,971

$1.62M

789
651 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 36%

$96
Average prescription price

Avg: $117

VIPUL PARIKH MD

Specialist

16,079

$1.01M

657
484 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 36%

$63
Average prescription price

Avg: $117

FAZAL PANEZAI M.D.

Specialist

15,800

$1.06M

729
598 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 36%

$67
Average prescription price

Avg: $117

STEPHEN BRUNNQUELL M.D.

Specialist

14,950

$944K

603
564 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

3%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 36%

$63
Average prescription price

Avg: $117

ANDREW SCHWARTZ M.D.

Specialist

14,792

$1.13M

663
599 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 36%

$76
Average prescription price

Avg: $117

HANY SOURIAL MD

Specialist

14,198

$884K

405
386 are 65+

20%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 36%

$62
Average prescription price

Avg: $117

EDGARDO ONG MD

Specialist

13,590

$781K

460
427 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 36%

$57
Average prescription price

Avg: $117

VINOD LALA MD

Specialist

13,192

$1.37M

675
502 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

2%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 36%

$104
Average prescription price

Avg: $117

JAMES PEREZ

Specialist

12,214

$1.01M

646
514 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 36%

$82
Average prescription price

Avg: $117

DARSHI SUNDERAM MD

Specialist

12,055

$1.31M

439
285 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 36%

$108
Average prescription price

Avg: $117

SALEH KHADDASH M.D.

Specialist

11,928

$897K

571
418 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 36%

$75
Average prescription price

Avg: $117

MOHAMED KAWAM M.D.

Specialist

11,872

$800K

358
161 are 65+

44%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 36%

$67
Average prescription price

Avg: $117

DANIEL KIM M.D.

Specialist

11,597

$1.53M

1739
1677 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

83%
prescriptions for brand name drugs

Avg: 36%

$132
Average prescription price

Avg: $117

GUILLERMO MUNOZ

Specialist

10,190

$1.01M

749
591 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 36%

$100
Average prescription price

Avg: $117

NIGAHUS KARABULUT MD

Specialist

9,804

$2.19M

263
100 are 65+

67%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 36%

$224
Average prescription price

Avg: $117

SARIKA SHARMA M.D.

Specialist

9,765

$853K

378
340 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

3%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 36%

$87
Average prescription price

Avg: $117

SYED HUSSAINI MD

Specialist

9,424

$630K

339
330 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 36%

$67
Average prescription price

Avg: $117

GNANA SUNDERAM MD

Specialist

9,396

$823K

344
226 are 65+

18%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 36%

$88
Average prescription price

Avg: $117

JOHN HWANG

Specialist

9,263

$854K

476
437 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 36%

$92
Average prescription price

Avg: $117

JEAN DARBOUZE MD

Specialist

8,838

$571K

178
126 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 36%

$65
Average prescription price

Avg: $117

NAIL ABDEL-FATAH MD

Specialist

8,652

$697K

375
261 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 36%

$81
Average prescription price

Avg: $117

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank